Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TUNDRA-AF: K201 in Atrial Fibrillation
NCT01259622Phase 2Terminated
- Sponsor
- Sequel Pharmaceuticals
- Start
- Feb 2011
- Primary completion
- Oct 2011
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of K201 in Atrial fibrillation (AFib), sponsored by Sequel Pharmaceuticals. Started Feb 2011; status: terminated.
02
Drugs
K201
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT01259622.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01259622.